Medical Journals

Mdma Induces Caspase-3 Activation in the Limbic System but Not in Striatum.

Authors:
  • Tamburini Ilaria
  • Blandini Fabio
  • Gesi Marco
  • Frenzilli Giada
  • Nigro Marco
  • Giusiani Mario
  • Paparelli Antonio
  • Fornai Francesco

From: Department of Human Morphology and Applied Biology, Univerity of Pisa, Via Roma 55, 56126 Pisa, Italy.

Annals of the New York Academy of Sciences

  • Publish Date: Aug 2006
  • ISSN: 0077-8923
  • Volume: 1074
  • Issue:
  • Pages: 377-81
  • Medium: Print
  • Language: English
  • Citation (JAMA): Tamburini Ilaria, Blandini Fabio, Gesi Marco, et al. Mdma Induces Caspase-3 Activation in the Limbic System but Not in Striatum.. Ann. N. Y. Acad. Sci. Aug 2006;1074:377-81

Abstract

Several studies, carried out in chronic (+/-) 3,4-methylenedioxymethamphetamine (MDMA) abusers, have shown memory loss and cognitive impairment, as well as persistent electroencephalographic changes. This suggests that, at least in humans, forebrain areas, including the limbic system, might be altered by MDMA. Consistently, recent experimental evidences suggest that, in rodents, MDMA, besides effects on the basal ganglia, produces alterations in the hippocampus. Therefore, the aim of the present article was to investigate whether treatment with MDMA produces activation of the caspase-3 enzyme, which is part of an enzymatic pathway involved in cell death, within limbic areas (i.e., hippocampus, amygdala, and piriform cortex) and striatum. A marked induction of caspase-3 activity was demonstrated in the amygdala and hippocampus, although MDMA did not affect caspase-3 activity neither in the striatum nor in the frontal cortex. These data indicate that limbic structures possess a high sensitivity to MDMA with respect to the activation of at least one step in the apoptotic pathway. Potential implications and pitfalls of such an experimental observation are reported.

Mesh Headings (Keywords): Animals, Caspase 3, Corpus Striatum, Enzyme Activation, Limbic System, Male, Mice, Mice, Inbred C57BL, N-Methyl-3,4-methylenedioxyamphetamine


Check for Full Text / PubMed Unique Identifier (PMID): 17105935


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.